Cytokine Receptor Lab, VIB Department of Medical Protein Research, VIB, UGent, Albert Baertsoenkaai 3, B-9000 Gent, Belgium.
Mol Cell Endocrinol. 2013 Nov 5;380(1-2):41-54. doi: 10.1016/j.mce.2012.12.014. Epub 2012 Dec 23.
The activity of the glucocorticoid receptor (GR), a nuclear receptor transcription factor belonging to subclass 3C of the steroid/thyroid hormone receptor superfamily, is typically triggered by glucocorticoid hormones. Apart from driving gene transcription via binding onto glucocorticoid response elements in regulatory regions of particular target genes, GR can also inhibit gene expression via transrepression, a mechanism largely based on protein:protein interactions. Hereby GR can influence the activity of other transcription factors, without contacting DNA itself. GR is known to inhibit the activity of a growing list of immune-regulating transcription factors. Hence, GCs still rule the clinic for treatments of inflammatory disorders, notwithstanding concomitant deleterious side effects. Although patience is a virtue when it comes to deciphering the many mechanisms GR uses to influence various signaling pathways, the current review is testimony of the fact that groundbreaking mechanistic work has been accumulating over the past years and steadily continues to grow.
糖皮质激素受体 (GR) 的活性,作为核受体转录因子,属于甾体/甲状腺激素受体超家族的第 3C 亚类,通常由糖皮质激素激素触发。除了通过结合特定靶基因调控区中的糖皮质激素反应元件来驱动基因转录外,GR 还可以通过反式阻遏抑制基因表达,这种机制主要基于蛋白质:蛋白质相互作用。由此,GR 可以影响其他转录因子的活性,而无需与 DNA 本身接触。已知 GR 会抑制一系列免疫调节转录因子的活性。因此,尽管 GC 会产生一些有害的副作用,但它们仍然是治疗炎症性疾病的临床用药。尽管在破译 GR 影响各种信号通路的多种机制方面需要耐心,但目前的综述证明了一个事实,即在过去几年中,开创性的机制研究工作一直在积累,并在稳步增长。